Obesity in COVID-19: A Systematic Review and Meta-analysis

Abstract

Objective: Obesity has been shown to be associated with adverse outcomes in viral infections such as influenza, but previous studies on coronavirus disease 2019 (COVID-19) had mixed results. The aim of this systematic review is to investigate the relationship between COVID-19 and obesity. Methods: We performed a systematic review and meta-analysis. A literature search of MEDLINE, EMBASE, Scopus, Web of Science, CENTRAL, OpenGrey and preprint servers medRxiv and bioRxiv was performed, with no restriction on language or date of publication. Primary outcomes of this study were intensive care unit (ICU) admission or critical disease, severe disease and mortality. Secondary outcome was a positive COVID-19 test. Meta-analysis was performed using OpenMeta-Analyst software, and heterogeneity was tested using Cochran’s Q test and I2 statistic. The study protocol was registered on PROSPERO (CRD42020184953). Results: A total of 1,493 articles were identified and 61 studies on 270,241 patients were included. The pooled prevalence of obesity was 27.6% (95% confidence interval [CI] 22.0–33.2) in hospitalised patients. Obesity was not significantly associated with increased ICU admission or critical illness (odds ratio [OR] 1.25, 95% CI 0.99–1.58, P=0.062, I2=31.0) but was significantly associated with more severe disease (OR 3.13, 95% CI 1.41–6.92, P=0.005, I2=82.6), mortality (OR 1.36, 95% CI 1.09–1.69, P=0.006, I2=88.5) and a positive COVID-19 test (OR 1.50, 95% CI 1.25–1.81, P<0.001). Conclusion: Obesity increased the risk of severe disease, mortality and infection with COVID-19. Higher body mass index was associated with ICU admission and critical disease. Patients who are obese may be more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and infected patients should be monitored closely for adverse outcomes. Keywords: Body mass index, coronavirus, intensive care, mortality, prognosis

A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19

“…None of which had been able to demonstrate utility in the treatment of COVID-19. Therefore, the efforts were focused on the development of the vaccines and so far, there are several drugs on the market that are able to relieve some of the tension placed on the healthcare system by COVID-19 [11,12]. However, while vaccination programs are widespread and the number of vaccinated patients grows, the underlying risk factors for the severe course of COVID-19 are still being investigated.…”

Role of bariatric surgery in a COVID-19 era: a review of economic costs

“…In fact, one report on COVID-19 found that obesity was a more significant risk factor for hospital admission than cardiovascular disease 45 . In a recent systematic review on obesity and COVID-J o u r n a l P r e -p r o o f 19, obesity was shown to have a significant association to higher COVID-19 infection rates (OR 1.50, P<0.001), more severe COVID-19 disease (OR 3.13, 95%; P=0.005) and higher mortality (OR 1.36, 95% P = 0.006) 43 . Bariatric surgery again has an important role in managing obesity-related COVID-19 complications, with one multi-center study finding that patients who have undergone bariatric surgery 12 months or earlier developed less severe COVID-19-related symptoms than subjects who were currently obese 46 .…”

“…This is especially true in light of the COVID-19 pandemic, where obesity serves as a risk factor for increased severity of symptoms from COVID-19 viral infections. Obesity was associated with increased need for hospitalization, mechanical ventilation, and increased mortality rates 43 .…”

“…This is especially true in light of the COVID-19 pandemic, where obesity serves as a risk factor for increased severity of symptoms from COVID-19 viral infections. Obesity was associated with increased need for hospitalization, mechanical ventilation, and increased mortality rates 43 . This may be explained due to the decreased respiratory system compliance and functional capacity, as well as increased incidence of comorbidities such as cardiac disease 44 .…”

Covid-19 and Lung Damage in Obese Patients

“…Пандемия COVID-19 произошла в то время, когда количество людей с избыточным весом/ожирением растет, по сути, во всех странах мира [16,17]. В настоящее время количество лиц с избыточным весом/ожирением превышает 20%, и ни в одной стране мира не отмечается тенденция к снижению числа указанных лиц [18][19][20]. Обращает внимание, что наличие сопутствующей патологии (сахарного диабета и сердечно-сосудистых заболеваний) связано с более тяжелым течением COVID-19, тогда как ожирение до сих пор практически не исследовалось.…”